Guardant Health
advanced cancer detection technology
- B2B
- B2C
About Guardant Health
Develops advanced blood and tissue tests using AI and real-world data to improve cancer detection, monitoring, and treatment selection.
Key facts
- Industry
- Biotechnology Research
- Company size
- 1,001–5,000 employees
- Headquarters
- Palo Alto, California, United States
- Founded
- 2012
- Revenue
- $982MFY2025, publicly reported
- Website
- guardanthealth.com
Guardant Health in the news
- Guardant Health (GH): Evaluating Valuation After FDA Approval Expands Guardant360 CDx Utility in Breast Cancer Care
Guardant Health's FDA approval for its breast cancer diagnostic test has driven strong stock gains and suggests modest undervaluation amid growth and risk factors.
- Guardant Health (GH): Valuation Spotlight as Quest Deal Expands Shield Test Access and Fuels Growth Optimism
Guardant Health’s partnership with Quest Diagnostics to expand its FDA-approved colorectal cancer blood test is fueling stock growth and optimism despite some valuation concerns.
- Guardant Health’s Strong Growth Trajectory and Unique Oncology Approach Earns Buy Rating
Guardant Health’s strong oncology diagnostics growth and unique epigenetics focus have led analysts to raise price targets and maintain Buy ratings despite insider selling.
- Guardant Health Hosts Investor Day in NYC
Guardant Health plans an Investor Day in NYC to discuss its cancer blood test business, financial outlook, and strategic priorities amid mixed analyst ratings.
- Quest to distribute Guardant colon cancer blood test
Guardant Health and Quest Diagnostics will collaborate to distribute the FDA-approved Shield blood test for colorectal cancer screening starting in 2026, with plans to expand it to multi-cancer detection.
Guardant Health at a glance
Guardant Health is a B2B/B2C company in the Biotechnology Research industry, headquartered in Palo Alto, California, United States.
Guardant Health was founded in 2012.
Guardant Health has 1,001–5,000 employees.
Guardant Health's revenue is $982M (FY2025, publicly reported).
Selling to companies like Guardant Health?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies